Dexamethasone, solution for injection 4mg/ml; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml vials; Isosorbide, concentrate/solution, 1 mg/ml, 10 ml vials; Furosemide, solution for injection, 10mg/ml, 2 ml vials

This tender is for the supply of several essential pharmaceutical products in injectable forms. The items include Dexamethasone solution for injection (4mg/ml), Magnesium sulfate solution for injection (250 mg/ml in 5 ml vials), Isosorbide concentrate/solution (1 mg/ml in 10 ml vials), and Furosemide solution for injection (10mg/ml in 2 ml vials). The description specifies that delivery will be in batches according to the Customer's requests, within 10 calendar days of receiving a request. The listed CPV codes are 33640000-8 (Medicinal products for treatment of genito-urinary system and hormones), 33620000-2 (Medicinal products for treatment of blood and blood-forming organs and cardiovascular system). These medications are commonly used in various medical settings for treating conditions such as inflammation, electrolyte imbalances, heart conditions, and fluid retention. The requirement for batch delivery indicates a need for ongoing supply to meet clinical demands. This procurement is crucial for healthcare facilities to ensure the availability of these vital injectable drugs for patient treatment.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 187,480.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.